The era of molecular subtyping in breast cancer has revolutionized staging, prognosis and prediction in treatment. It has also brought about increasing ability to predict risk and more selectively choose treatments for individual patients. Breast radiotherapy has also expanded to offer more directed and highly effective approaches that require less time and result in lower exposure to normal tissues. The prediction methods as well as latest treatment approaches will be highlighted in addition to areas of continued investigation and controversy.